Marine Derived Anticancer Drugs Targeting Microtubule

E-ISSN： 2212-3970|12|2|102-127

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.12, Iss.2, 2017-06, pp. : 102-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Microtubule-targeting Anticancer Agents from Marine Natural Substance

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 3, 2014-01 ,pp. : 409-417

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Cancer Drugs Targeting Fatty Acid Synthase (FAS)

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 2, 2012-05 ,pp. : 185-197

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Status of Anti-Cancer Agents Derived from Marine Sources

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 6, 2008-08 ,pp. : 603-617

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Therapeutic Strategies Against Cancer: Marine-derived Drugs May Be the Answer?

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 12, 2016-12 ,pp. : 1549-1557

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs

By Sun Yanlin

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 591-599

Springer Publishing Company

Access to resources Recommend Favorite